In tumor tissues, we found that CRC patients with positive VPS9D1-AS1 expression shown higher levels of TGF-β, TGFBR1, and SMAD1/5/9 (Figure 1D-E). This evidence concerns the gene VPS9D1 and colorectal carcinoma.